{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:01:24Z","timestamp":1786132884897,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1681\/asn.2014040400","type":"journal-article","created":{"date-parts":[[2014,11,14]],"date-time":"2014-11-14T01:00:46Z","timestamp":1415926846000},"page":"1173-1180","source":"Crossref","is-referenced-by-count":45,"title":["Contrasting Cholesterol Management Guidelines for Adults with CKD"],"prefix":"10.1681","volume":"26","author":[{"given":"Lisandro D.","family":"Colantonio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usman","family":"Baber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Banach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikki M.","family":"Tanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Warnock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orlando M.","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika M.","family":"Safford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Wanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Muntner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-21-20230208","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/01.CIR.0000031732.78052.81","article-title":"Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population.","volume":"106","author":"Hillege","year":"2002","journal-title":"Circulation"},{"key":"R2-21-20230208","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ki.2010.536","article-title":"Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts.","volume":"79","author":"van der Velde","year":"2011","journal-title":"Kidney Int"},{"key":"R3-21-20230208","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis.","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"},{"key":"R4-21-20230208","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1001\/jama.2012.16817","article-title":"Age and association of kidney measures with mortality and end-stage renal disease.","volume":"308","author":"Hallan","year":"2012","journal-title":"JAMA"},{"key":"R5-21-20230208","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1053\/j.ajkd.2013.04.010","article-title":"CKD and cardiovascular disease in the Atherosclerosis Risk in Communities (ARIC) study: Interactions with age, sex, and race.","volume":"62","author":"Hui","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"R6-21-20230208","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.phrs.2013.03.007","article-title":"Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy\u2014a meta-analysis of 11 randomized controlled trials involving 21,295 participants.","volume":"72","author":"Barylski","year":"2013","journal-title":"Pharmacol Res"},{"key":"R7-21-20230208","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): A randomised placebo-controlled trial.","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"R8-21-20230208","doi-asserted-by":"crossref","first-page":"251","DOI":"10.7326\/0003-4819-157-4-201208210-00005","article-title":"Lipid-lowering therapy in persons with chronic kidney disease: A systematic review and meta-analysis.","volume":"157","author":"Upadhyay","year":"2012","journal-title":"Ann Intern Med"},{"key":"R9-21-20230208","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/bmj.39472.580984.AE","article-title":"Effects of statins in patients with chronic kidney disease: Meta-analysis and meta-regression of randomised controlled trials.","volume":"336","author":"Strippoli","year":"2008","journal-title":"BMJ"},{"key":"R11-21-20230208","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines.","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"key":"R12-21-20230208","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines.","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"key":"R13-21-20230208","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jacc.2007.03.037","article-title":"The Framingham predictive instrument in chronic kidney disease.","volume":"50","author":"Weiner","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R14-21-20230208","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(12)60572-8","article-title":"Risk of coronary events in people with chronic kidney disease compared with those with diabetes: A population-level cohort study.","volume":"380","author":"Tonelli","year":"2012","journal-title":"Lancet"},{"key":"R15-21-20230208","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1053\/j.ajkd.2009.09.020","article-title":"Effect of lovastatin on primary prevention of cardiovascular events in mild CKD and kidney function loss: A post hoc analysis of the Air Force\/Texas Coronary Atherosclerosis Prevention Study.","volume":"55","author":"Kendrick","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"R16-21-20230208","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.atherosclerosis.2009.03.031","article-title":"Pravastatin and cardiovascular risk in moderate chronic kidney disease.","volume":"206","author":"Nakamura","year":"2009","journal-title":"Atherosclerosis"},{"key":"R17-21-20230208","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.jacc.2010.01.020","article-title":"Efficacy of rosuvastatin amongmen and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: A secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evaluating Rosuvastatin) trial.","volume":"55","author":"Ridker","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R19-21-20230208","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1053\/j.ajkd.2013.11.014","article-title":"Potential effects of reclassifying CKD as a coronary heart disease risk equivalent in the US population.","volume":"63","author":"Foster","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"R20-21-20230208","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1053\/j.ajkd.2006.09.017","article-title":"The impact of reclassifying moderate CKD as a coronary heart disease risk equivalent on the number of US adults recommended lipid-lowering treatment.","volume":"49","author":"Hyre","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"R21-21-20230208","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1056\/NEJMoa1315665","article-title":"Application of new cholesterol guidelines to a population-based sample.","volume":"370","author":"Pencina","year":"2014","journal-title":"N Engl J Med"},{"key":"R22-21-20230208","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1001\/jama.2014.2630","article-title":"Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations.","volume":"311","author":"Muntner","year":"2014","journal-title":"JAMA"},{"key":"R23-21-20230208","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1053\/j.ajkd.2008.12.016","article-title":"CKD as an underrecognized threat to patient safety.","volume":"53","author":"Fink","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"R24-21-20230208","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1053\/j.ackd.2010.06.004","article-title":"Medication-related problems in CKD.","volume":"17","author":"Cardone","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"key":"R25-21-20230208","doi-asserted-by":"crossref","first-page":"664","DOI":"10.2215\/CJN.09091010","article-title":"The efficacy and safety of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors in chronic kidney disease, dialysis, and transplant patients.","volume":"6","author":"Olyaei","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R26-21-20230208","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1001\/jama.2013.252441","article-title":"Prevalence of reduced estimated glomerular filtration rate among the oldest old from 1988-1994 through 2005-2010.","volume":"310","author":"Bowling","year":"2013","journal-title":"JAMA"},{"key":"R27-21-20230208","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.2337\/dc12-2258","article-title":"The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010.","volume":"36","author":"Stark Casagrande","year":"2013","journal-title":"Diabetes Care"},{"key":"R28-21-20230208","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000086678","article-title":"The reasons for geographic and racial differences in stroke study: Objectives and design.","volume":"25","author":"Howard","year":"2005","journal-title":"Neuroepidemiology"},{"key":"R29-21-20230208","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1001\/jama.2012.14306","article-title":"Association of race and sex with risk of incident acute coronary heart disease events.","volume":"308","author":"Safford","year":"2012","journal-title":"JAMA"},{"key":"R30-21-20230208","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"R31-21-20230208","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.ejheart.2004.08.003","article-title":"Evaluation of the performance and concordance of clinical questionnaires for the diagnosis of heart failure in primary care.","volume":"6","author":"Fonseca","year":"2004","journal-title":"Eur J Heart Fail"},{"key":"R32-21-20230208","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/j.ajkd.2008.05.004","article-title":"Kidney function and cognitive impairment in US adults: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.","volume":"52","author":"Kurella Tamura","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"R33-21-20230208","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate.","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"R35-21-20230208","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1161\/CIRCULATIONAHA.107.187397","article-title":"Universal definition of myocardial infarction.","volume":"116","author":"Thygesen","year":"2007","journal-title":"Circulation"},{"key":"R36-21-20230208","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1161\/01.CIR.0000100560.46946.EA","article-title":"Case definitions for acute coronary heart disease in epidemiology and clinical research studies: A statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute.","volume":"108","author":"Luepker","year":"2003","journal-title":"Circulation"},{"key":"R39-21-20230208","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.jacc.2012.01.025","article-title":"Prolongation of QTc and risk of stroke: The REGARDS (REasons for Geographic and Racial Differences in Stroke) study.","volume":"59","author":"Soliman","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R41-21-20230208","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/oxfordjournals.aje.a113284","article-title":"A review of goodness of fit statistics for use in the development of logistic regression models.","volume":"115","author":"Lemeshow","year":"1982","journal-title":"Am J Epidemiol"},{"key":"R42-21-20230208","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.","volume":"15","author":"Harrell","year":"1996","journal-title":"Stat Med"},{"key":"R43-21-20230208","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/sim.1802","article-title":"Overall C as a measure of discrimination in survival analysis: Model specific population value and confidence interval estimation.","volume":"23","author":"Pencina","year":"2004","journal-title":"Stat Med"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201505000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:25:27Z","timestamp":1786130727000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201505000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2014040400","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]}}}